Tissue distribution of sodium p-perfluorous nonenoxybenzene sulfonate (OBS) in mice via oral exposure

Environ Int. 2022 Jul:165:107289. doi: 10.1016/j.envint.2022.107289. Epub 2022 May 11.

Abstract

Environmental risks caused by emerging per- and polyfluoroalkyl substances (PFASs) have attracted increasing attention. As an important substitute for perfluorooctane sulfonate (PFOS), sodium p-perfluorous nonenoxybenzene sulfonate (OBS) is widely used as a firefighting foam additive and oil recovery agent in China. This study reported the tissue distribution of OBS in KM mice that were administered a dose of OBS at 10 µg/day via daily oral gavage for 7, 14, or 28 days. During exposure, gender-based differences were observed in body weight changes and tissue distribution of OBS. Liver exhibited the highest concentrations (males: 12.57 ± 1.80 µg/g; females: 11.80 ± 5.32 µg/g) and tissue/blood ratios and contributed more than 50% to the whole-body burden of OBS in both male and female mice, showing its ability to enrich PFASs. Furthermore, there were certain differences in the distribution characteristics of the three OBS isomers. Based on its bioaccumulation potential and widespread use, further studies are required on the human exposure risks of OBS.

Keywords: Mice; OBS; Oral gavage; Tissue distribution.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkanesulfonates
  • Alkanesulfonic Acids*
  • Animals
  • Bioaccumulation
  • Female
  • Fluorocarbons* / toxicity
  • Male
  • Mice
  • Sodium
  • Tissue Distribution

Substances

  • Alkanesulfonates
  • Alkanesulfonic Acids
  • Fluorocarbons
  • Sodium